is glp 1 a specialty drug 2026 Employee Benefits Trends: Should You Cover GLP‑1s for Weight Loss? Specialty Physicians on Using GLP-1

Type 2 diabetes is driven by a combination of insulin resistance, reduced insulin production over time, and excess glucose output from the liver

The GLP-1 Nausea Timeline: Why Nausea Often Fluctuates Nausea is one of the most recognizable GLP-1 side effects

Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP: Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

The first-line treatment with vildagliptin/pioglitazone (both high- and low-dose regimens) provided better glycemic control than each component monotherapy with minimal hypoglycemia

GLP-1 receptor agonists also reduce the three components of MACE, including CV mortality (reduced by 13%), nonfatal stroke (reduced by 16%) and nonfatal myocardial infarction (reduced by 9%, although the level of significance was not reached)

In pancreatic cells, GLP-1 binds GLP-1R to promote the conversion of ATP into cytoplasmic cAMP, further activating the intracellular PKA/AMPK signaling pathway and promoting glucose-stimulated insulin secretion (GSIS) (Kahn, 2001)